Topic: Reuters Group plc
LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks to reduce costs.Britain's second biggest drugmaker said on Wednesday it would cut about 1,150 sales ...
(Reuters) - AstraZeneca said it will cut about 1,150 U.S. sales jobs, and expects to take a related charge of about $50-$100 million in the fourth quarter.The company said the job cuts, which will account for about 24 percent of the company's ...
LONDON (Reuters) - British scientists have made the first human embryonic stem cells of a high enough grade to use in patients and deposited them in a public stem cell bank for development in human trials by drug companies and researchers by ...
ZURICH (Reuters) - Novartis' Sandoz unit has agreed to pay $150 million Swiss francs to settle claims it charged the U.S. and state governments inflated prices for drugs, a Swiss newspaper reported on Sunday.Under the deal Novartis will pay the U.S. government ...
(Reuters) - Apple Inc named long-serving director Arthur Levinson chairman of its board, filling a seat vacated by co-founder Steve Jobs, who died in October after a years-long struggle with cancer.Walt Disney Co CEO Bob Iger, who had a strong relationship with ...
NEW ORLEANS (Reuters) - The American Medical Association threw its support behind government efforts to ensure the supply of lifesaving medicines but stopped short of recommending financial penalties against drug companies.The influential doctors' lobby voted on Monday to back legislation to create ...
ZURICH (Reuters) - Swiss drugmaker Novartis AG is slashing 2,000 jobs in Switzerland and the United States as it seeks to rake in annual savings of more than $200 million in the face of growing price pressures and the strong Swiss franc.The ...
LONDON (Reuters) - Europe will strictly limit the amount of information that drugmakers can supply to the public on prescription-only medicines and retain a ban on advertising under proposed rules set out on Tuesday.The latest proposals from the European Commission amend those ...
(Reuters) - AstraZeneca Plc said on Thursday it will cut about 400 jobs from its U.S. commercial business as Britain's second-largest drugmaker seeks to reduce costs.The cuts will hit the company's U.S. headquarters in Wilmington, Delaware, as well as some field-based, non-sales ...
ZURICH (Reuters) - Swiss drugmaker Novartis cut 2,500 jobs at sites across the world in a bid to control costs, the daily Tages Anzeiger reported on Saturday.Like many pharmaceutical companies, Novartis is starting to face generic competition, with its breast cancer drug ...
